2021 Pediatric RX, Module 7: Nutraceuticals
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide an up-to-date information on integrating the current evidence regarding the use of supplements in children into primary care pediatric practice.
INTRODUCTION: This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours, of which 1.0 is pharmacology content.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright 2021 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Define nutraceuticals.
- Identify commonly used nutraceuticals.
- Review current evidence for integration into pediatrics.
- Discuss recommendations and resources for patients and families.
Debra P. Shockey, DNP, RN, CPNP; An associate professor, Virginia Commonwealth University, PNP in a pediatric hematology/oncology clinic.
Dr. Shockey has no financial relationships with any commercial entities to disclose, and will not discuss off label use and/or investigational use of individual drugs in this presentation.
- 1.00 Contact hours